Loading…

Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas

The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (GBM) with oligodendroglioma component (GBMO) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. In this study, we performed a histopathology-base...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2012-07, Vol.7 (7), p.e41669-e41669
Main Authors: Kanno, Hiromi, Nishihara, Hiroshi, Narita, Takuhito, Yamaguchi, Shigeru, Kobayashi, Hiroyuki, Tanino, Mishie, Kimura, Taichi, Terasaka, Shunsuke, Tanaka, Shinya
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c802t-20f76040ebfecc432b4b8a4a1a74d5309f37916abfd292a70f5ab218a08267cb3
cites cdi_FETCH-LOGICAL-c802t-20f76040ebfecc432b4b8a4a1a74d5309f37916abfd292a70f5ab218a08267cb3
container_end_page e41669
container_issue 7
container_start_page e41669
container_title PloS one
container_volume 7
creator Kanno, Hiromi
Nishihara, Hiroshi
Narita, Takuhito
Yamaguchi, Shigeru
Kobayashi, Hiroyuki
Tanino, Mishie
Kimura, Taichi
Terasaka, Shunsuke
Tanaka, Shinya
description The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (GBM) with oligodendroglioma component (GBMO) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. In this study, we performed a histopathology-based reevaluation of 111 cases of high grade gliomas according to the latest World Health Organization (WHO), and compared the clinical outcomes between oligodendroglial tumors and pure astrocytic tumors. The survival analysis revealed that the patients with high grade oligodendroglial tumor including GBMO significantly indicated better prognosis compared to the patients with high grade pure astrocytic tumors (GBM and AA, anaplastic astrocytoma) as expected, and the obtained survival curves were almost identical to those from the patients with conventional Grade III or Grade IV tumors, respectively. Moreover, if the cases of oligodendroglial tumor were histopathologically excluded, the patients with AA exhibited extremely poor prognosis which was similar to that of GBM, suggesting that the histological identification of oligodendroglial tumor component, even partially, prescribe the prognosis of high grade glioma patients. This is the prominent report of retrospective clinicopathological analysis for high-grade gliomas throughout Grade III and IV, especially referring to the prognostic value of histological oligodendroglial tumor component; in addition, our results might offer an alternative aspect for the grading of high-grade astrocytic/oligodendroglial tumors.
doi_str_mv 10.1371/journal.pone.0041669
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1327116412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A477045830</galeid><doaj_id>oai_doaj_org_article_9e86df755f514b099c38ee609cc92b83</doaj_id><sourcerecordid>A477045830</sourcerecordid><originalsourceid>FETCH-LOGICAL-c802t-20f76040ebfecc432b4b8a4a1a74d5309f37916abfd292a70f5ab218a08267cb3</originalsourceid><addsrcrecordid>eNqNk1uL1DAUx4so7rr6DUQLgujDjLm1aXwQlsXLwMKKt9dwmqadDGkyNqm4n8CvbbrTHWZkH6QPaU5-538uycmypxgtMeX4zcaPgwO73HqnlwgxXJbiXnaKBSWLkiB6_-D_JHsUwgahglZl-TA7IURgXFFxmv35PPjO-RCNyk2_tUZBNN7lvs3XJkRvfZdMNvfWdL7Rrkm4NckQx94PufL9FN_Ft7myxhnltxDXey9ICV4HEyY5jHGuIOibTQ9Jz4GLeVLzPYTH2YMWbNBP5vUs-_7h_beLT4vLq4-ri_PLhaoQiQuCWl4ihnTdaqUYJTWrK2CAgbOmoEi0lAtcQt02RBDgqC2gJrgCVJGSq5qeZc93ulvrg5x7GCSmhGNcMkwSsdoRjYeN3A6mh-FaejDyxuCHTsKQ2mW1FLoqm5YXRVtgViMhFK20LpFQSpC6oknr3RxtrHvdqNSoAeyR6PGJM2vZ-V-SslQkmpJ5NQsM_ueoQ5S9CUpbC077MeWNKKsQ5Ygn9MU_6N3VzVQHqQDjWp_iqklUnjPOESsqihK1vINKX6P7dMdOtybZjxxeHzkkJurfsYMxBLn6-uX_2asfx-zLA3atwcZ18Hac3mg4BtkOVIMPYdDtvskYyWlebrshp_cq53lJbs8OL2jvdDsg9C8OHRJl</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1327116412</pqid></control><display><type>article</type><title>Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Kanno, Hiromi ; Nishihara, Hiroshi ; Narita, Takuhito ; Yamaguchi, Shigeru ; Kobayashi, Hiroyuki ; Tanino, Mishie ; Kimura, Taichi ; Terasaka, Shunsuke ; Tanaka, Shinya</creator><contributor>Kano, Mitsunobu R.</contributor><creatorcontrib>Kanno, Hiromi ; Nishihara, Hiroshi ; Narita, Takuhito ; Yamaguchi, Shigeru ; Kobayashi, Hiroyuki ; Tanino, Mishie ; Kimura, Taichi ; Terasaka, Shunsuke ; Tanaka, Shinya ; Kano, Mitsunobu R.</creatorcontrib><description>The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (GBM) with oligodendroglioma component (GBMO) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. In this study, we performed a histopathology-based reevaluation of 111 cases of high grade gliomas according to the latest World Health Organization (WHO), and compared the clinical outcomes between oligodendroglial tumors and pure astrocytic tumors. The survival analysis revealed that the patients with high grade oligodendroglial tumor including GBMO significantly indicated better prognosis compared to the patients with high grade pure astrocytic tumors (GBM and AA, anaplastic astrocytoma) as expected, and the obtained survival curves were almost identical to those from the patients with conventional Grade III or Grade IV tumors, respectively. Moreover, if the cases of oligodendroglial tumor were histopathologically excluded, the patients with AA exhibited extremely poor prognosis which was similar to that of GBM, suggesting that the histological identification of oligodendroglial tumor component, even partially, prescribe the prognosis of high grade glioma patients. This is the prominent report of retrospective clinicopathological analysis for high-grade gliomas throughout Grade III and IV, especially referring to the prognostic value of histological oligodendroglial tumor component; in addition, our results might offer an alternative aspect for the grading of high-grade astrocytic/oligodendroglial tumors.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0041669</identifier><identifier>PMID: 22911839</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Astrocytoma ; Brain cancer ; Brain tumors ; Cancer therapies ; Child ; Chromosomes ; Classification ; Comparative analysis ; Development and progression ; Disease-Free Survival ; Female ; Gangrene ; Glioblastoma ; Glioma ; Gliomas ; Histochemistry ; Histology ; Histopathology ; Humans ; Hybridization ; In Situ Hybridization, Fluorescence ; Laboratories ; Male ; Medical diagnosis ; Medical prognosis ; Medical research ; Medical schools ; Medicine ; Middle Aged ; Multivariate analysis ; Neurosurgery ; Oligodendroglioma ; Oligodendroglioma - diagnosis ; Oligodendroglioma - drug therapy ; Oligodendroglioma - pathology ; Pathology ; Patients ; Prognosis ; Surgery ; Survival ; Survival analysis ; Tumors ; Young Adult</subject><ispartof>PloS one, 2012-07, Vol.7 (7), p.e41669-e41669</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>2012 Kanno et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Kanno et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c802t-20f76040ebfecc432b4b8a4a1a74d5309f37916abfd292a70f5ab218a08267cb3</citedby><cites>FETCH-LOGICAL-c802t-20f76040ebfecc432b4b8a4a1a74d5309f37916abfd292a70f5ab218a08267cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1327116412/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1327116412?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22911839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kano, Mitsunobu R.</contributor><creatorcontrib>Kanno, Hiromi</creatorcontrib><creatorcontrib>Nishihara, Hiroshi</creatorcontrib><creatorcontrib>Narita, Takuhito</creatorcontrib><creatorcontrib>Yamaguchi, Shigeru</creatorcontrib><creatorcontrib>Kobayashi, Hiroyuki</creatorcontrib><creatorcontrib>Tanino, Mishie</creatorcontrib><creatorcontrib>Kimura, Taichi</creatorcontrib><creatorcontrib>Terasaka, Shunsuke</creatorcontrib><creatorcontrib>Tanaka, Shinya</creatorcontrib><title>Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (GBM) with oligodendroglioma component (GBMO) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. In this study, we performed a histopathology-based reevaluation of 111 cases of high grade gliomas according to the latest World Health Organization (WHO), and compared the clinical outcomes between oligodendroglial tumors and pure astrocytic tumors. The survival analysis revealed that the patients with high grade oligodendroglial tumor including GBMO significantly indicated better prognosis compared to the patients with high grade pure astrocytic tumors (GBM and AA, anaplastic astrocytoma) as expected, and the obtained survival curves were almost identical to those from the patients with conventional Grade III or Grade IV tumors, respectively. Moreover, if the cases of oligodendroglial tumor were histopathologically excluded, the patients with AA exhibited extremely poor prognosis which was similar to that of GBM, suggesting that the histological identification of oligodendroglial tumor component, even partially, prescribe the prognosis of high grade glioma patients. This is the prominent report of retrospective clinicopathological analysis for high-grade gliomas throughout Grade III and IV, especially referring to the prognostic value of histological oligodendroglial tumor component; in addition, our results might offer an alternative aspect for the grading of high-grade astrocytic/oligodendroglial tumors.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Astrocytoma</subject><subject>Brain cancer</subject><subject>Brain tumors</subject><subject>Cancer therapies</subject><subject>Child</subject><subject>Chromosomes</subject><subject>Classification</subject><subject>Comparative analysis</subject><subject>Development and progression</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Gangrene</subject><subject>Glioblastoma</subject><subject>Glioma</subject><subject>Gliomas</subject><subject>Histochemistry</subject><subject>Histology</subject><subject>Histopathology</subject><subject>Humans</subject><subject>Hybridization</subject><subject>In Situ Hybridization, Fluorescence</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medical schools</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Neurosurgery</subject><subject>Oligodendroglioma</subject><subject>Oligodendroglioma - diagnosis</subject><subject>Oligodendroglioma - drug therapy</subject><subject>Oligodendroglioma - pathology</subject><subject>Pathology</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Surgery</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1uL1DAUx4so7rr6DUQLgujDjLm1aXwQlsXLwMKKt9dwmqadDGkyNqm4n8CvbbrTHWZkH6QPaU5-538uycmypxgtMeX4zcaPgwO73HqnlwgxXJbiXnaKBSWLkiB6_-D_JHsUwgahglZl-TA7IURgXFFxmv35PPjO-RCNyk2_tUZBNN7lvs3XJkRvfZdMNvfWdL7Rrkm4NckQx94PufL9FN_Ft7myxhnltxDXey9ICV4HEyY5jHGuIOibTQ9Jz4GLeVLzPYTH2YMWbNBP5vUs-_7h_beLT4vLq4-ri_PLhaoQiQuCWl4ihnTdaqUYJTWrK2CAgbOmoEi0lAtcQt02RBDgqC2gJrgCVJGSq5qeZc93ulvrg5x7GCSmhGNcMkwSsdoRjYeN3A6mh-FaejDyxuCHTsKQ2mW1FLoqm5YXRVtgViMhFK20LpFQSpC6oknr3RxtrHvdqNSoAeyR6PGJM2vZ-V-SslQkmpJ5NQsM_ueoQ5S9CUpbC077MeWNKKsQ5Ygn9MU_6N3VzVQHqQDjWp_iqklUnjPOESsqihK1vINKX6P7dMdOtybZjxxeHzkkJurfsYMxBLn6-uX_2asfx-zLA3atwcZ18Hac3mg4BtkOVIMPYdDtvskYyWlebrshp_cq53lJbs8OL2jvdDsg9C8OHRJl</recordid><startdate>20120724</startdate><enddate>20120724</enddate><creator>Kanno, Hiromi</creator><creator>Nishihara, Hiroshi</creator><creator>Narita, Takuhito</creator><creator>Yamaguchi, Shigeru</creator><creator>Kobayashi, Hiroyuki</creator><creator>Tanino, Mishie</creator><creator>Kimura, Taichi</creator><creator>Terasaka, Shunsuke</creator><creator>Tanaka, Shinya</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120724</creationdate><title>Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas</title><author>Kanno, Hiromi ; Nishihara, Hiroshi ; Narita, Takuhito ; Yamaguchi, Shigeru ; Kobayashi, Hiroyuki ; Tanino, Mishie ; Kimura, Taichi ; Terasaka, Shunsuke ; Tanaka, Shinya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c802t-20f76040ebfecc432b4b8a4a1a74d5309f37916abfd292a70f5ab218a08267cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Astrocytoma</topic><topic>Brain cancer</topic><topic>Brain tumors</topic><topic>Cancer therapies</topic><topic>Child</topic><topic>Chromosomes</topic><topic>Classification</topic><topic>Comparative analysis</topic><topic>Development and progression</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Gangrene</topic><topic>Glioblastoma</topic><topic>Glioma</topic><topic>Gliomas</topic><topic>Histochemistry</topic><topic>Histology</topic><topic>Histopathology</topic><topic>Humans</topic><topic>Hybridization</topic><topic>In Situ Hybridization, Fluorescence</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medical schools</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Neurosurgery</topic><topic>Oligodendroglioma</topic><topic>Oligodendroglioma - diagnosis</topic><topic>Oligodendroglioma - drug therapy</topic><topic>Oligodendroglioma - pathology</topic><topic>Pathology</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Surgery</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kanno, Hiromi</creatorcontrib><creatorcontrib>Nishihara, Hiroshi</creatorcontrib><creatorcontrib>Narita, Takuhito</creatorcontrib><creatorcontrib>Yamaguchi, Shigeru</creatorcontrib><creatorcontrib>Kobayashi, Hiroyuki</creatorcontrib><creatorcontrib>Tanino, Mishie</creatorcontrib><creatorcontrib>Kimura, Taichi</creatorcontrib><creatorcontrib>Terasaka, Shunsuke</creatorcontrib><creatorcontrib>Tanaka, Shinya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints (Gale)</collection><collection>Gale in Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kanno, Hiromi</au><au>Nishihara, Hiroshi</au><au>Narita, Takuhito</au><au>Yamaguchi, Shigeru</au><au>Kobayashi, Hiroyuki</au><au>Tanino, Mishie</au><au>Kimura, Taichi</au><au>Terasaka, Shunsuke</au><au>Tanaka, Shinya</au><au>Kano, Mitsunobu R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-07-24</date><risdate>2012</risdate><volume>7</volume><issue>7</issue><spage>e41669</spage><epage>e41669</epage><pages>e41669-e41669</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (GBM) with oligodendroglioma component (GBMO) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. In this study, we performed a histopathology-based reevaluation of 111 cases of high grade gliomas according to the latest World Health Organization (WHO), and compared the clinical outcomes between oligodendroglial tumors and pure astrocytic tumors. The survival analysis revealed that the patients with high grade oligodendroglial tumor including GBMO significantly indicated better prognosis compared to the patients with high grade pure astrocytic tumors (GBM and AA, anaplastic astrocytoma) as expected, and the obtained survival curves were almost identical to those from the patients with conventional Grade III or Grade IV tumors, respectively. Moreover, if the cases of oligodendroglial tumor were histopathologically excluded, the patients with AA exhibited extremely poor prognosis which was similar to that of GBM, suggesting that the histological identification of oligodendroglial tumor component, even partially, prescribe the prognosis of high grade glioma patients. This is the prominent report of retrospective clinicopathological analysis for high-grade gliomas throughout Grade III and IV, especially referring to the prognostic value of histological oligodendroglial tumor component; in addition, our results might offer an alternative aspect for the grading of high-grade astrocytic/oligodendroglial tumors.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>22911839</pmid><doi>10.1371/journal.pone.0041669</doi><tpages>e41669</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2012-07, Vol.7 (7), p.e41669-e41669
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1327116412
source Publicly Available Content Database; PubMed Central
subjects Adolescent
Adult
Aged
Aged, 80 and over
Astrocytoma
Brain cancer
Brain tumors
Cancer therapies
Child
Chromosomes
Classification
Comparative analysis
Development and progression
Disease-Free Survival
Female
Gangrene
Glioblastoma
Glioma
Gliomas
Histochemistry
Histology
Histopathology
Humans
Hybridization
In Situ Hybridization, Fluorescence
Laboratories
Male
Medical diagnosis
Medical prognosis
Medical research
Medical schools
Medicine
Middle Aged
Multivariate analysis
Neurosurgery
Oligodendroglioma
Oligodendroglioma - diagnosis
Oligodendroglioma - drug therapy
Oligodendroglioma - pathology
Pathology
Patients
Prognosis
Surgery
Survival
Survival analysis
Tumors
Young Adult
title Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A08%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20implication%20of%20histological%20oligodendroglial%20tumor%20component:%20clinicopathological%20analysis%20of%20111%20cases%20of%20malignant%20gliomas&rft.jtitle=PloS%20one&rft.au=Kanno,%20Hiromi&rft.date=2012-07-24&rft.volume=7&rft.issue=7&rft.spage=e41669&rft.epage=e41669&rft.pages=e41669-e41669&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0041669&rft_dat=%3Cgale_plos_%3EA477045830%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c802t-20f76040ebfecc432b4b8a4a1a74d5309f37916abfd292a70f5ab218a08267cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1327116412&rft_id=info:pmid/22911839&rft_galeid=A477045830&rfr_iscdi=true